Status:

UNKNOWN

Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction

Lead Sponsor:

Deutsches Herzzentrum Muenchen

Conditions:

Myocardial Infarction

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Randomized comparison of two different anticoagulation strategies: prasugrel plus bivalirudin versus clopidogrel plus heparin in patients with acute myocardial infarction undergoing emergency catheter...

Detailed Description

Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion strategy for patients with acute ST-segment elevation myocardial infarction (STEMI). Additional anticoagulation therapy p...

Eligibility Criteria

Inclusion

  • Patients presenting within 24 hours from the onset of symptoms with STEMI
  • Informed, written consent
  • In women with childbearing potential a pregnancy test is obligatory.

Exclusion

  • Age \< 18 years
  • Cardiogenic shock
  • Active bleeding; bleeding diathesis; coagulopathy
  • History of gastrointestinal or genitourinary bleeding \<2 months
  • Refusal to receive blood transfusion
  • Major surgery in the last 6 weeks
  • History of intracranial bleeding or structural abnormalities
  • Suspected aortic dissection
  • Heparin-induced thrombocytopenia
  • Any previous stroke
  • Prior administration of thrombolytics, bivalirudin, low-molecular weight heparin or fondaparinux for the index MI
  • Known relevant hematological deviations: Hb \<100g/l, Thromb. \<100x10\^9/l
  • Use of coumadin derivatives within the last 7 days
  • Chronic therapy with nonsteroidal anti-inflammatory drugs (except aspirin), COX-2 inhibitors, prasugrel
  • Known malignancies or other comorbid conditions with life expectancy \<1 year
  • Known severe liver disease, severe renal failure
  • Known allergy to the study medications
  • Previous enrollment in this trial
  • Pregnancy

Key Trial Info

Start Date :

September 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2015

Estimated Enrollment :

548 Patients enrolled

Trial Details

Trial ID

NCT00976092

Start Date

September 1 2009

End Date

February 1 2015

Last Update

January 7 2014

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Deutsches Herzzentrum Muenchen

Munich, Bavaria, Germany, 80636

2

Klinikum rechts der Isar, Technische Universitaet Muenchen

Munich, Bavaria, Germany, 81674

3

Herzzentrum der Segeberger Kliniken

Bad Segeberg, Germany, 23795